Trisomy 8 Involved in Myelodysplastic Syndromes as a Risk Factor for Intestinal Ulcers and Thrombosis — Behçet's Syndrome

References

• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A.G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Boogaerts M. A., Nelissen V., Roelant C., Goossens W. Blood neutrophil function in primary myelodysplastic syndromes. British Journal of Haematology 1983; 55: 217–227
   PubMed Web of Science ®Google Scholar
• Tsurumi H., Shimazaki M., Takahashi T., Moriwaki H., Muto Y. How cytometric determination of active oxygen (hydroperoxide) produced by peripheral blood neutrophils in patients with hematological disorders. International Journal of Hematology 1993; 57: 213–219
   PubMed Web of Science ®Google Scholar
• Yuo A., Kitagawa S., Okabe T., Urabe A., Komatsu Y., Itoh S., Takaku F. Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 1987; 70: 404–411
   PubMed Web of Science ®Google Scholar
• Niwa Y., Miyake S., Sakane T., Shingu M., Yokoyama M. Auto-oxidative damage in Behcet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clinical Experimental Immunology 1982; 49: 247–255
   PubMed Web of Science ®Google Scholar
• Nehashi Y., Torii Y., Yaguchi M., Itoh Y., Ohyashiki K., Toyama K. Incomplete-form of Behçet disease in a case of monopathic myelodysplastic syndrome presenting as a thrombocytopenia. Japanese Journal of Clinical Hematology 1988; 29: 1097–1102
   PubMedGoogle Scholar
• Nakayama S., Ishikawa T., Yabe H., Nagai K. Refractory anemia complicated by Behçet's disease. Japanese Journal of Clinical Hematology 1989; 30: 530–534
   PubMedGoogle Scholar
• Chyuma Y., Utsunomiya A., Saito T., Hanada S., Nishimata H., Arima T. Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome. Japanese Journal of Clinical Hematology 1992; 33: 333–337
   PubMedGoogle Scholar
• Takishita N., Horiuchi T., Hato T., Fujita S., Kobayashi Y. Myelodysplastic syndrome complicated with Behçet's disease. Ehime Igaku 1991; 11: 39–43
   Google Scholar
• Molina M., Aguayo J. L., Ortega G., de Paco M., Cuesta F., Agudo M. D. Non-specific digestive ulcers and Behçet's disease. Anates de Medicina Interna 1992; 9: 237–238
   PubMedGoogle Scholar
• Yoshizawa Y., Hirai A., Izaki S., Kitamura K. Behçet's disease associated with myelodysplastic disorder. Hifu Rinsyo 1992; 34: 1585–1589
   Google Scholar
• Kageyama H., Hidaka T., Kondo S., Tamaru K. Intestinal Behçet's disease associated with myelodysplastic syndrome. Japanese Journal of Clinical Hematology 1993; 34: 1288
   Google Scholar
• Yano K., Eguchi K., Migita K., Takashima H., Tamura M., Izumino K., Sasagawa I., Sadamori N., Nagataki S. Behçet's disease complicated with myelodysplastic syndrome. A report of two cases and review of the literature. Clinical Rheumatology 1996; 15: 91–93
   PubMed Web of Science ®Google Scholar
• Ohno E., Ohtsuka E., Watanabe K., Kohno T., Takeoka K., Saburi Y., Kikuchi H., Nasu M. Behçet's disease associated with myelodysplastic syndromes. Cancer 1997; 79: 262–268
   PubMed Web of Science ®Google Scholar
• Mitelman F. ISCN Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Karger, BaselSwitzerland 1995
   Google Scholar
• Kuroda J., Kimura S., Akaogi T., Hayashi H., Nishida K., Taniwaki M., Kashima K., Abe T., Kobayashi Y, Kondo M. c-myc overexpression is not mandatory in aggressive phase multiple myeloma with Burkitt's type translocation. Annals of Hematology, in press
   Web of Science ®Google Scholar
• Takada Y., Fujita Y., Igarashi M., Katsumata T., Okabe H., Saigenji K., Takahashi T., Atari E. Intestinal Behçet's disease-pathognomonic changes in intramucosal lymphoid tissues and effect of a “rest cure” on intestinal leisions. Journal of Gastroenterology 1997; 32: 598–604
   PubMed Web of Science ®Google Scholar
• Ohno S. Behçet's disease in the world. Recent advances in Behçet's disease, T. Lehner, C. G. Barnes. Royal Society of Medicine Service, New York 1986; 181–186
   Google Scholar
• Sole F., Prieto F., Badia L., Woessner S., Florensa L., Caballin M. R., Coll M. D., Besses C., Sans-Sabrafen J. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genetics and Cytogenetics 1992; 64: 12–20
   PubMed Web of Science ®Google Scholar
• Ohno S., Matsuda H. Studies of HLA antigens in Behçet's disease in Japan. Recent advances in Behçet's disease, T. Lehner, C. G. Barnes. Royal Society of Medicine Service, New York 1986; 11–15
   Google Scholar
• Negrin R. S., Haeuber D. H., Nagler A., Kobayashi Y., Sklar J., Donlon T., Vincent M., Greenberg P. L. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 1990; 76: 36–43
   PubMed Web of Science ®Google Scholar
• Saitoh K., Miura I., Takahashi N., Miura A. B. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Blood 1998; 92: 2886–2892
   PubMed Web of Science ®Google Scholar
• Okamoto T., Okada M., Itoh T., Mori A., Saheki K., Takatsuka H., Wada H., Tamura A., Fujimori Y., Takemoto Y., Kanamaru A., Kakishita E. Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation. International Journal of Hematology 1998; 68: 61–65
   PubMed Web of Science ®Google Scholar
• Billstrom R., Johansson B., Strombeck B., El-Rifai W., Larramendy M., Olofsson T., Mitelman F., Knuutila S. Clonal CD5-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8. Annals of Hematology 1997; 74: 37–40
   PubMed Web of Science ®Google Scholar
• Kimura S., Maekawa T., Hirakawa K., Murakami A., Abe T. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Research 1995; 55: 1379–1384
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Croce C. M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America 1982; 79: 7824–7827
   PubMed Web of Science ®Google Scholar
• Diaz M. O., Le Beau M. M., Harden A., Rowley J. D. Trisomy 8 in human hematologic neoplasia and the c-myc and c-mos oncogenes. Leukemia Research 1985; 9: 1437–1442
   PubMed Web of Science ®Google Scholar
• Blick M., Romero P., Talpaz M., Kurzrock R., Shtalrid M., Andersson B., Trujillo J., Beran M., Gutterman J. Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genetics and Cytogenetics 1987; 27: 349–356
   PubMed Web of Science ®Google Scholar
• Jennings B. A., Mills K. I. c-myc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukaemia. Leukemia Research 1998; 22: 899–903
   PubMed Web of Science ®Google Scholar